227 related articles for article (PubMed ID: 6168364)
1. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR
Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364
[TBL] [Abstract][Full Text] [Related]
2. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.
Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K
Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202
[TBL] [Abstract][Full Text] [Related]
3. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Shah NT; Tuttle SE; Strobel SL; Gandhi L
J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
[TBL] [Abstract][Full Text] [Related]
4. Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Rizk CC; Scholes J; Chen SK; Ward J; Romas NA
Urology; 1990 Dec; 36(6):526-30. PubMed ID: 1701066
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Epstein JI; Eggleston JC
Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
[TBL] [Abstract][Full Text] [Related]
6. Prostatic origin of tumors. An immunohistochemical study.
Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
[TBL] [Abstract][Full Text] [Related]
7. Immunoperoxidase localization of prostate-specific antigen.
Stein BS; Vangore S; Petersen RO; Kendall AR
Am J Surg Pathol; 1982 Sep; 6(6):553-7. PubMed ID: 6183983
[TBL] [Abstract][Full Text] [Related]
8. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Ellis DW; Leffers S; Davies JS; Ng AB
Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
[TBL] [Abstract][Full Text] [Related]
10. Crescentic glomerulonephritis associated with prostatic carcinoma: evidence of immune-mediated glomerular injury.
Haskell LP; Fusco MJ; Wadler S; Sablay LB; Mennemeyer RP
Am J Med; 1990 Feb; 88(2):189-92. PubMed ID: 1689105
[No Abstract] [Full Text] [Related]
11. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Horoszewicz JS; Kawinski E; Murphy GP
Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
13. Atypical metastasis from prostate cancer. Clinical utility of the immunoperoxidase technique for prostate-specific antigen.
Tell DT; Khoury JM; Taylor HG; Veasey SP
JAMA; 1985 Jun; 253(24):3574-5. PubMed ID: 2582156
[TBL] [Abstract][Full Text] [Related]
14. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
[No Abstract] [Full Text] [Related]
16. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
[TBL] [Abstract][Full Text] [Related]
18. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer.
Baker WC; Meyers FJ; White RW
J Surg Oncol; 1988 Mar; 37(3):165-7. PubMed ID: 2451087
[TBL] [Abstract][Full Text] [Related]
19. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
20. Localization of a normal prostatic secretory product using the monoclonal antibody KR-P8.
Raynor RH; Mohanakumar T; Moncure CW; Hazra TA
J Urol; 1985 Aug; 134(2):384-7. PubMed ID: 2410635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
